MedPath

The Effect of Processed Tomato Products on CVD Risks

Not Applicable
Completed
Conditions
Cardiovascular Disease
Interventions
Dietary Supplement: Tomato products
Registration Number
NCT00937742
Lead Sponsor
Penn State University
Brief Summary

The primary working hypothesis is that consuming processed tomatoes frequently/daily will favorably improve endothelium and platelet function disease-risk biomarker profiles in adult men and women compared to consuming no or relatively low amounts of processed tomatoes.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
32
Inclusion Criteria

men and women (>21 <70 years) nonsmokers, with a body mass index (BMI) ranging of 25 to 35 kg/m2, BP < or = 140/90 mmHg

Exclusion Criteria
  1. Total cholesterol (TC) is greater than 300 mg/dL;
  2. Fasting triglyceride is greater than 300 mg/dL;
  3. LDL cholesterol (LDL-C) is greater than 180 mg/dL;
  4. Female subjects who are pregnant or lactating;
  5. Subjects who are actively losing weight or trying to lose weight;
  6. Subjects with known allergy or intolerance to tomato products;
  7. taking any medications that would interfere with outcomes of the study, ie. lipid lowering medications, anti-inflammatory drugs, dietary supplements, such as fish oil or evening primrose;
  8. subjects' with documented atherosclerotic disease, inflammatory disease, diabetes mellitus, uncontrolled hypertension (>=140/90 mm Hg - ok if controlled below this limit with medication), or other systemic diseases;
  9. subjects with low hematological counts as determined by >or <15% the upper or lower cut-off values of normal established for the lab;
  10. Smokers. -

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Non-tomato productsTomato productsNon-tomato products (i.e. teriyaki marinade, sprite, applesauce) to be consumed daily in replace of tomato products
Primary Outcome Measures
NameTimeMethod
Vascular functionBaseline and end of intervention phase (week 6)
Platelet and monocyte function/activityBaseline and end of intervention phase (week 6)
Secondary Outcome Measures
NameTimeMethod
LipidsBaseline and end of intervention phase (week 6)
Insulin/GlucoseBaseline and end of intervention phase (week 6)
Inflammatory MarkersBaseline and end of intervention phase (week 6)

Trial Locations

Locations (1)

Penn State University

🇺🇸

University Park, Pennsylvania, United States

© Copyright 2025. All Rights Reserved by MedPath